Autologous stem cell transplantation for malignant lymphomas.
Bone Marrow Transplant
; 22 Suppl 4: S104-6, 1998 Dec.
Article
em En
| MEDLINE
| ID: mdl-9916651
ABSTRACT
From December 1995 to April 1998, 20 consecutive adult patients suffering from chemosensitive relapse of Hodgkin's or non-Hodgkin lymphoma (11 Hodgkin, 9 non-Hodgkin Lymphoma) received autologous stem cell transplantation. The median follow up period is 15 months (range 6-28). The overall survival is 18/20 (90 %), the event free survival is 13/20 (65%). None of the patients died of transplant related cause.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Linfoma não Hodgkin
/
Doença de Hodgkin
/
Transplante de Células-Tronco Hematopoéticas
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Bone Marrow Transplant
Ano de publicação:
1998
Tipo de documento:
Article